Chemical Compound

5-Oxorosuvastatin methyl ester

CAS Registry Number 147118-39-6
5-Oxorosuvastatin methyl ester chemical structure
Primary Record

5-Oxorosuvastatin methyl ester

In stock
9,163 g
Purity
98.1 %
CAS
147118-39-6

Compound Identifiers & Properties

CAS
147118-39-6
PubChem CID
22848603
SMILES
CC(C)C1=NC(=NC(=C1/C=C/C(=O)C[C@H](CC(=O)OC)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C
Canonical SMILES
COC(=O)C[C@H](O)CC(=O)/C=C/c1c(-c2ccc(F)cc2)nc(N(C)S(C)(=O)=O)nc1C(C)C

Names & Synonyms

  • 5-Oxorosuvastatin methyl ester
  • 147118-39-6
  • MFCD12755726
  • RefChem:407473
  • 5-Oxorosuvastatinmethylester
  • SCHEMBL3786
  • C23H28FN3O6S
  • ULUNETUXUVEFLH-DOJUMQAQSA-N
  • DTXSID601102631
  • BCP10934
  • AN-367
  • ZINC38339138
  • Rosuvastatin 5-Oxo Acid Methyl Ester
  • AKOS015896426
  • AC-3411
  • AJ-95120
  • AS-11331
  • SC-22832
  • SY111426
  • TC-133136
  • CS-0145870
  • FT-0657382
  • ST24024178
  • J3.546.491C
  • A24796
  • C72799
  • (R,E)-Methyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate
  • 118M396
  • 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-, methyl ester, (3R,6E)-
  • I06-2014
  • Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-(6E)-heptenoate
  • (R,E)-Methyl 7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)-pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate
  • 6-?Heptenoic acid, 7-?[4-?(4-?fluorophenyl)?-?6-?(
  • methyl (E,3R)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-propan-2-ylpyrimidin-5-yl]-3-hydroxy-5-oxohept-6-enoate
  • Methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-hydroxy-5-oxo-(E)-6-heptenate
  • Methyl(+)-(3-R)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methy
  • Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-Methansulphonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-6(E)-heptenoate
  • Methyl (3R,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoate
  • methyl (E,3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-3-hydroxy-5-oxo-hept-6-enoate
  • Methyl(+)-(3-R)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesul fonylamino) pyrimidin-5-yl]-3-hydroxy-5-oxo-6(E)-heptenoate
  • Methyl - -7-[4- -6-isopropyl-2- pyrimidin-5-yl]-3-hydroxy-5-oxo-6 -heptenoate
  • (3R,6E)-7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]pyrimidine-5-yl]-3-hydroxy-5-oxo-6-heptenoic acid methyl ester
  • (3R,E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonylamino)pyrimidine-5-yl]-3-hydroxy-5-oxo-6-heptenoic acid methyl ester
  • (R,E)-Methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]-3-hydroxy-5-oxohept-6-enoate
  • (r,e)-methyl7-(4-(4-fluorophenyl)-6-isopropyl-2-(n-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoate
  • 5-Oxorosuvastatin Methyl Ester; 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-, methyl ester, (3R,6E)-; 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-, methyl ester, [R-(E)]-; Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-Methansulphonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-6(E)-heptenoate; Methyl (3R,6E)-7-{4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl}-3-hydroxy-5-oxo-6-heptenoate
  • 6-?Heptenoic acid, 7-?[4-?(4-?fluorophenyl)?-?6-?(1-?methylethyl)?-?2-?[methyl(methylsulfon?yl)?amino]?-?5-?pyrimidinyl]?-?3-?hydroxy-?5-?oxo-?, methyl ester, (3R,?6E)?-
  • 6-Heptenoic acid, 7-[4-(4-fluorophenyl)-6-(1-methyle thyl)-2-[methyl(methylsulfonyl) amino]-5-pyrimidinyl]-3-hydroxy -5-oxo-, methyl ester, (3R,6E)-
  • 604-567-0
  • 7-[4-(4-Fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3-hydroxy-5-oxo-6-heptenoic acid methyl ester
  • 7-[4-fluorophenyl]-6-isopropyl)-2-(N-Methyl-N-MethylSulfonyl amino)pyrimidine-5-yl]-(3R)-3-(terbutyldimethylsilyloxy)-5-oxo-6E-heptane acid,Methyl ester
  • Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-metha nesulfonylamino)pyrimidin-5-yl]-3-hydroxy-5-oxo-(6E)-heptenoa te
  • Methyl (+)-(3R)-7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)pyrimidin -5-yl]-3-hydroxy-5-oxo-(6E)-heptenoate
  • Methyl (3R,6E)-7-(4-(4-fluorophenyl)-6-(1-methylethyl)-2-(methyl(methylsulfonyl)amino)-5-pyrimidinyl)-3-hydroxy-5-oxo-6-heptenoate
  • methyl (3R,6E)-7-[4-(4-fluorophenyl)-2-(N-methylmethanesulfonamido)-6-(propan-2-yl)pyrimidin-5-yl]-3-hydroxy-5-oxohept-6-enoate
  • Methyl (R,E)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl]-3-hydroxy-5-oxohept-6-enoate
  • Methyl(+)-(3-R)-7-[4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino) pyrimidin-5-yl]-3-hydroxy-5-oxo-6(E)-heptenoate
  • Rosuvastatin intermediate;Methyl 7-[4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonylamino)pyrimidin-5-yl]-(3R)-3-hydroxy-5-oxo-(E)-6-heptenate